Literature DB >> 785952

Piracetam-induced improvement of mental performance. A controlled study on normally aging individuals.

P Mindus, B Cronholm, S E Levander, D Schalling.   

Abstract

A double-blind, intra-individual cross-over comparison of the mental performance of 18 aging, non-deteriorated individuals during two 4-week periods of piracetam (1-acetamide-2-pyrrolidone) and placebo administration was performed using conventional and computerized perceptual-motor tasks. In a majority of these tasks the subjects did significantly better when on piracetam than on placebo, a finding consistent with ratings completed by two independent observers. The findings indicate new avenues for the treatment of individuals with reduced mental performance possibly related to disturbed alertness--a neglected group of psychiatric conditions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 785952     DOI: 10.1111/j.1600-0447.1976.tb00107.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  12 in total

1.  A new chemotherapeutic investigation: Piracetam effects on dyslexia.

Authors:  C H Chase; R L Schmitt; G Russell; P Tallal
Journal:  Ann Dyslexia       Date:  1984-01

2.  The nootropic concept and dyslexia.

Authors:  C R Wilsher
Journal:  Ann Dyslexia       Date:  1986-01

Review 3.  Piracetam in developmental reading disorders: A review.

Authors:  Colin R Wilsher; Eric A Taylor
Journal:  Eur Child Adolesc Psychiatry       Date:  1994-04       Impact factor: 4.785

4.  Radial maze as a tool for assessing the effect of drugs on the working memory of rats.

Authors:  O Buresová; J Bures
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

5.  Effects of piracetam on brain monoamine metabolism and serum prolactin levels in the rat.

Authors:  H Nybäck; F A Wiesel; P Skett
Journal:  Psychopharmacology (Berl)       Date:  1979-03-28       Impact factor: 4.530

6.  Aniracetam tested in chronic psychosyndrome after long-term exposure to organic solvents. A randomized, double-blind, placebo-controlled cross-over study with neuropsychological tests.

Authors:  F E Somnier; M S Ostergaard; G Boysen; P Bruhn; B O Mikkelsen
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Metipranolol and propranolol: no CNS effects of a single oral dose.

Authors:  S Levander; A Gillner
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Piracetam in elderly psychiatric patients with mild diffuse cerebral impairment.

Authors:  G Chouinard; L Annable; A Ross-Chouinard; M Olivier; F Fontaine
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 9.  Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders.

Authors:  M W Vernon; E M Sorkin
Journal:  Drugs Aging       Date:  1991-01       Impact factor: 3.923

10.  Effects of piracetam on regional cerebral blood flow and mental functions in patients with organic dementia.

Authors:  L Gustafson; J Risberg; M Johanson; M Fransson; V A Maximilian
Journal:  Psychopharmacology (Berl)       Date:  1978-03-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.